Research progress on targeted regulatory proteins in the prevention and treatment of atherosclerosis - Takeaways - MDSpire

Research progress on targeted regulatory proteins in the prevention and treatment of atherosclerosis

  • By

  • Yuxin Wei

  • Fengmei Zhang

  • Yuanpeng Liao

  • Yan Zhao

  • Jiawei Guo

  • July 1, 2026

  • 0 min

Share

  • 1

    Atherosclerosis is a chronic inflammatory disease driven by lipid metabolic dysregulation and immune cell interactions.

  • 2

    Key regulatory proteins, including epigenetic modifiers and transcription factors, play critical roles in atherogenesis.

  • 3

    Histone deacetylases (HDACs) exhibit isoform-specific effects on atherosclerosis, influencing inflammation and vascular remodeling.

  • 4

    HDAC3 has dual roles, exacerbating inflammation in macrophages while also exhibiting protective signaling in vascular smooth muscle cells.

  • 5

    The review emphasizes the importance of understanding complex molecular networks for developing precision-targeted therapies for cardiovascular disease.

Original Source(s)

Related Content